Avid Bioservices, Inc., a biologics CDMO, has appointed Dave Stewart as Chief Technology and Transformation Officer, a newly created role designed to advance the company’s next phase of growth.

The addition of this role is part of CEO Kenneth Bilenberg’s strategy to position Avid for continued expansion.

In this new role, Stewart will lead Avid’s integration of technology and process transformation initiatives across Avid’s development and manufacturing network. His focus will include digital modernization, automation, and integration of new advanced tools and service capabilities across Avid’s development and manufacturing network. Working closely with Avid’s team, he will work to ensure the company’s systems and platforms enable greater efficiency, alignment, and flexibility as the organization continues to expand.

“Avid has built tremendous momentum over the past several years, and as we look ahead, we are making deliberate investments in people, processes and the systems that will power our future,” said Kenneth Bilenberg, President and Chief Executive Officer of Avid Bioservices. “Knowing Dave as a key industry leader, I’m confident in the expertise and integrity he brings to this important role. His leadership supports our vision to be the easiest external partner to work with – reliable, predictable, and proactive at every stage – while continuing to expand what we already do exceptionally well for our clients and their patients.”

“I’ve long admired Avid’s reputation for quality and its unwavering focus on patients,” said Stewart. “The people here care deeply about doing things the right way, and that commitment shows in every aspect of their work. Joining this team at such a dynamic point in its growth is a tremendous opportunity to contribute to a mission I believe in.”